Reply: Clinical efficacy of lenvatinib for the treatment of radioiodine‐refractory thyroid carcinoma: A systematic review and meta‐analysis of clinical trials. (15th March 2022)

Record Type:: Journal Article
Title:: Reply: Clinical efficacy of lenvatinib for the treatment of radioiodine‐refractory thyroid carcinoma: A systematic review and meta‐analysis of clinical trials. (15th March 2022)
Main Title:: Reply: Clinical efficacy of lenvatinib for the treatment of radioiodine‐refractory thyroid carcinoma: A systematic review and meta‐analysis of clinical trials
Authors:: Su, Jingyang
Fu, Yue
Wang, Menglei
Lin, Shengyou
Abstract:
Is Part Of:: Clinical endocrinology. Volume 98:Number 2(2023)
Journal:: Clinical endocrinology
Issue:: Volume 98:Number 2(2023)
Issue Display:: Volume 98, Issue 2 (2023)
Year:: 2023
Volume:: 98
Issue:: 2
Issue Sort Value:: 2023-0098-0002-0000
Page Start:: 275
Page End:: 276
Publication Date:: 2022-03-15
Subjects:: lenvatinib -- meta‐analysis -- radioiodine‐refractory thyroid carcinoma -- systematic review
Endocrinology -- Periodicals
616.4005
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2265 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/cen.14718 ↗
Languages:: English
ISSNs:: 0300-0664
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3286.278000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 25598.xml